United Kingdom Issues New Adverse Event Reporting Guidelines
This article was originally published in The Gray Sheet
Executive Summary
New guidelines spell out that manufacturers who sell medical devices in the United Kingdom have no more than two calendar days after becoming aware of a "serious public health threat" to file an initial adverse event report with the country's Medicines and Healthcare Products Regulatory Agency
You may also be interested in...
U.K. Regulatory Agency Prioritizes Safety Over International Standards Work
The U.K.'s Medicines and Healthcare Products Regulatory Agency (MHRA) has turned its focus away from international standards work to concentrate instead on investigating medical device safety issues
U.K. Regulatory Agency Prioritizes Safety Over International Standards Work
The U.K.'s Medicines and Healthcare Products Regulatory Agency (MHRA) has turned its focus away from international standards work to concentrate instead on investigating medical device safety issues
Revised Guidance To Clarify Adverse Event Reporting Requirements In Europe
The revision of supplemental guidelines to the European Medical Device Directive (MDD) should help further clarify manufacturer obligations for postmarket event reporting, speakers suggested March 2 at IBC Life Sciences' Vigilance & Postmarket Surveillance for Medical Devices conference in London